Endo's Opana Patent Survives AIA Challenge By Amneal
The Patent Trial and Appeal Board on Wednesday rejected an America Invents Act challenge by Amneal Pharmaceuticals LLC to an Endo Pharmaceuticals Inc. patent related to the painkiller Opana ER, saying...To view the full article, register now.
Already a subscriber? Click here to view full article